Today: 8 June 2026
Diageo share price today: DGE edges up as investors size up the next big test
5 February 2026
1 min read

Diageo share price today: DGE edges up as investors size up the next big test

London, Feb 5, 2026, 09:54 GMT — Regular session

  • After surging sharply yesterday, Diageo shares edged up again in early London trading
  • Even with this week’s rebound, the stock remains far from its one-year high
  • Attention shifts to Diageo’s interim results due late February, along with new remarks from the management team

Diageo shares inched 0.17% higher to 1,777 pence during early trading in London on Thursday. The company’s RNS feed showed no new announcements for the day.

The slight shift hides a bigger issue looming over the stock: can the world’s largest spirits maker prove demand is steadying and that its turnaround efforts are gaining ground before its half-year earnings come out in February?

Shares climbed 4.54% on Wednesday, closing at 17.74 pounds—well ahead of the FTSE 100’s 0.85% gain. Still, Diageo’s stock ended the day roughly 24% off its 52-week peak of 23.38 pounds.

This gap is precisely why the upcoming update is crucial. Investors see Diageo as a bellwether for premium spirits demand and consumer spending, particularly in the U.S., its largest market.

Dave Lewis, who stepped in as CEO this January following his late last year appointment, has pledged a sense of urgency. “We think this is a good move,” noted RBC Capital Markets analyst James Edwardes Jones at the time. Lewis himself acknowledged, “The market faces some headwinds but there are also significant opportunities.” Reuters

The rebound might not hold up. In November, Diageo trimmed its fiscal 2026 outlook, citing softer demand in the U.S. and China, with sales expected to be flat or down slightly. Interim CEO Nik Jhangiani warned, “There’s much more for us to do, and we need to go faster.” Reuters

Traders will next focus on volumes compared to “price/mix”—a quick way to see if sales growth stems from higher prices and premium products instead of simply moving more bottles—and whether spirits demand is settling back after a rough period.

Diageo announced it will release interim results for the half-year ending Dec. 31, 2025, on Wednesday, Feb. 25. The company will host a webcast at 0705 UK time, followed by a Q&A session at 0930 UK time.

Stock Market Today

  • Singapore Stocks Slide 1.9% Amid Global Tech Sell-off and Middle East Tensions
    June 8, 2026, 5:33 AM EDT. Singapore's Straits Times Index (STI) dropped 1.9% to 4,955.47 on June 8, pressured by a global slump in technology shares and escalating Middle East conflicts. Major tech stocks, including AEM and UMS, fell between 3-4%, while precision engineering and AI-related firm InnoTek declined over 4%. Regional markets fell sharply, with South Korea's Kospi down 8.1%, Japan's Nikkei by 4%, and Taiwan's benchmark by 3.5%. Key chipmakers Samsung Electronics and SK Hynix saw steep losses of 9.5% and 6.5%, respectively. The tech sell-off followed Broadcom's weaker-than-expected revenue guidance, raising fears of an AI investment bubble. Local banks DBS, OCBC, and UOB also declined amid rising inflation concerns driven by higher oil prices and geopolitical risks. The volatile market reflects investor caution ahead of SpaceX's Nasdaq IPO slated for June 12.

Latest articles

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

8 June 2026
Hyperscale Data’s $0.21/share buyback offer sits 39% above Friday’s $0.1510 close, with the tender expiring late Monday and covering up to 5.1% of shares; the company cites a “material disconnect” with net book value at $0.26/share, while ending its ATM stock-sale program and holding $51.8M in Bitcoin as of May 31.
Zealand Pharma Shares Sink 25% After Trial Results

Zealand Pharma Shares Sink 25% After Trial Results

8 June 2026
Zealand Pharma shares plunged 26.02% to 241.40 Danish crowns after investors focused on a 19% discontinuation rate for Boehringer’s obesity drug survodutide in the SYNCHRONIZE-1 trial, far higher than the 2.9% for placebo, despite strong fat-loss data, making the stock the worst performer on Europe’s STOXX 600 in early trade.
Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

8 June 2026
Intel shares rose 1.6% to $100.74 in pre-market trading Monday, partly rebounding from Friday’s 7.9% drop that followed a strong U.S. jobs report and a tech selloff; investors now face a key test as Intel’s AI partnerships with Foxconn and others lack visible orders or financial details, while options pricing signals potential for another 9% stock move this week amid inflation data and shifting rate expectations.
Nvidia’s $5 Trillion Valuation Gets Put to the Test Monday

Nvidia’s $5 Trillion Valuation Gets Put to the Test Monday

8 June 2026
Nvidia shares hovered near Friday’s 6% drop and $300 billion market cap loss despite new South Korean AI deals, as chip stocks reeled from fears of higher U.S. rates and regulatory risks; investors await Monday’s open to see if fresh partnerships can offset sector volatility and valuation pressure.
Nokia drops after fast AI rally, traders stay focused

Nokia rally stalls as traders sell tech stocks after AI push

8 June 2026
Nokia shares plunged 2.98% in Helsinki to 12.690 euros, extending losses as investors dumped AI-linked tech stocks amid rising oil prices and rate fears; U.S. ADRs dropped 13.48% Friday, while no new operating update was given and Nokia issued 500 million euros in new debt, with the next key earnings test set for July 23.
IDBI Bank shares rally again as privatisation bid deadline hits; analyst flags ₹130 target
Previous Story

IDBI Bank shares rally again as privatisation bid deadline hits; analyst flags ₹130 target

Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite
Next Story

Volvo Car AB stock sinks 22% as Q4 profit slumps and tariffs bite

Go toTop